We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation.
- Authors
Bagyinszky, Eva; Kang, Min Ju; Pyun, Jungmin; Giau, Vo Van; An, Seong Soo A; Kim, SangYun
- Abstract
Background: In this study, a known PRNP mutation, Val180Ile (c.G538A), was reported in a 58 years old female patient, clinically diagnosed with Alzheimer's disease (AD). Case report: The patient presented slowly progressive cognitive decline in memory and visuospatial domain. Neuroimaging showed hippocampal atrophy in MRI and mild amyloid positivity in PET scan. Even though her cerebrospinal fluid (CSF) was positive for 14–3-3 protein, no sign of Creutzfeldt-Jakob diseases symptoms was observed. In addition, reduced Aβ42 and elevated total-Tau and phospho-Tau in CSF also proved the AD diagnosis. The mutation may disturb the hydrophobic core of prion protein, and result in abnormal intramolecular interactions. Due to 23andMe, PRNP Val180Ile could not be categorized either as a mutation with complete penetrance, or as neutral variant, and could have a possible role in neurodegeneration. Pathological overlap was observed between prion diseases and other neurodegenerative diseases, including AD or frontotemporal dementia. Conclusion: Whole exome sequencing and pathway analysis of patient revealed rare or possible risk variants in AD associated genes, such as SORL1 or ABCA7. Along with PRNP, AD risk genes may play a role in negative regulation of amyloid formation. Dysfunctions in these genes could possibly be associated in reduced neuroprotection and amyloid clearance.
- Subjects
FRONTOTEMPORAL lobar degeneration; BOVINE spongiform encephalopathy; ALZHEIMER'S patients
- Publication
Neuropsychiatric Disease & Treatment, 2019, Vol 15, p2003
- ISSN
1176-6328
- Publication type
Article
- DOI
10.2147/NDT.S215277